Cuizon, Senceridad B.
HRN: 13-77-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/13/2026
02/20/2026
IV
2.25
Q6h
Sepsis Sec To Complivated Uti
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines